Amodiaquine
- Generic Name
- Amodiaquine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H22ClN3O
- CAS Number
- 86-42-0
- Unique Ingredient Identifier
- 220236ED28
- Background
A 4-aminoquinoquinoline compound with anti-inflammatory properties.
- Indication
For treatment of acute malarial attacks in non-immune subjects.
- Associated Conditions
- -
- Associated Therapies
- -
Relationship Between HIV and Malaria in Ugandan Children
- First Posted Date
- 2006-07-26
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 300
- Registration Number
- NCT00356824
- Locations
- 🇺🇬
Pediatric Infectious Diseases Clinic, Mulago Hospital Complex, Kampala, Uganda
Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study
Phase 2
Completed
- Conditions
- Malaria
- First Posted Date
- 2006-07-20
- Last Posted Date
- 2006-10-24
- Lead Sponsor
- Heidelberg University
- Registration Number
- NCT00354380
- Locations
- 🇧🇫
Nouna District Hospital, Nouna, Burkina Faso
Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine
Phase 2
Completed
- Conditions
- Malaria
- Interventions
- Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049Biological: Hiberix®Biological: Engerix™-BBiological: Prevnar™Drug: sulfadoxine-pyrimethamineDrug: amodiaquine
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2016-12-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1737
- Registration Number
- NCT00323622
- Locations
- 🇲🇿
GSK Investigational Site, Maputo, Mozambique
Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso
Phase 2
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-12-02
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 120
- Registration Number
- NCT00261222
- Locations
- 🇧🇫
Centre de Recherche en Santé de Nouna (CRSN), Nouna, Burkina Faso
Chloroquine and Amodiaquine for Treatment of Malaria in Children
Phase 4
Completed
- Conditions
- Malaria, Falciparum
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2008-04-08
- Lead Sponsor
- Bandim Health Project
- Target Recruit Count
- 720
- Registration Number
- NCT00137514
- Locations
- 🇬🇼
Bandim Health Project, Apartado 861, Bissau, Guinea-Bissau
A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children
Phase 3
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 2200
- Registration Number
- NCT00132548
- Locations
- 🇸🇳
Institut de recherche pour le developpement, Dakar, Senegal
Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women
Phase 3
Completed
- Conditions
- MalariaPregnancy
- First Posted Date
- 2005-08-19
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 900
- Registration Number
- NCT00131703
Antimalarial Drug Resistance in Mali
Not Applicable
Completed
- Conditions
- Malaria
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2006-08-16
- Lead Sponsor
- Centers for Disease Control and Prevention
- Target Recruit Count
- 1011
- Registration Number
- NCT00127998
- Locations
- 🇲🇱
Koro Health Center, Koro, Mali
🇲🇱Faladje Missionary Dispensary, Faladje, Mali
🇲🇱Pongono Community Health Center, Pongono, Mali
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath